Ubie

Ubie

Private
New York City, New YorkHealthcare & Life Scienceshttps://ubiehealth.com/

Last Round

Series C

Extension

Jun 26, 2025

Total Funding Raised

$136.05M

Company Overview

Ubie is a health-tech company that develops an AI-powered platform to guide patients from symptoms to appropriate medical care and improve operational efficiency for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Marketing, Patient Engagement, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Freemium

AI Layer

Application

Keywords

AI symptom checkermedical AIpatient intakepatient discoveryAI doctorclinical triagehealthcare provider SaaSpharma marketingclinical workflowdigital healthpatient engagementvertical SaaSrare disease marketing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ubie Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ubie Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJun 26, 2025
DebtMay 7, 2025
Series C ExtensionDec 8, 2022
DebtDec 8, 2022
Series CAug 22, 2022
Series B
Jun 4, 2020

Key People

Founding team and executive leadership

Kota Kubo

Co-Founder CEO, Ubie U.S.

Founding Team

Shoko Suzuki

CEO And Director Of Singapore

Executive Team

Yuku Kotani

CTO

Executive Team

Ubie Investors

Notable investors and investment history

InvestorRounds
Shinsei Capital PartnersSeries C
株式会社日本政策金融公庫Series C Extension, Debt
Rakuten CapitalSeries C Extension
Norinchukin CapitalSeries C
NVenture Capital Co., Ltd.Series C
AAIC InvestmentSeries C Extension
GoogleSeries C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Launched a new LLM-based chat platform for patient health guidance.

  • Feb 12, 2026

    Developing AI platform with Mayo Clinic for patient navigation.

Ubie Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ubie Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ubie's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range239
Year Founded2017
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.